Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

Topic: Andrew von Eschenbach

FDA COMMISSIONER ANDREW VON ESCHENBACH
Acting Food and Drug Administration (FDA) Commissioner Andrew von Eschenbach testifies before a Senate Agriculture Subcommittee hearing on the FDA's FY2007 proposed budget, in Washington on March 14, 2006. (UPI Photo/Kevin Dietsch)

Latest Headlines

WASHINGTON, Nov. 18 (UPI) -- The U.S. Food and Drug Administration opened three offices in China this week as part of an effort to improve the safety of food imported from the Asian nation.
FDA: Food protection plan shows progress
WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration says its plan to keep U.S. citizens enjoying one of the safest food supplies in the world shows significant progress.
WASHINGTON, April 9 (UPI) -- The U.S. Food and Drug Administration has appointed Dr. Frank Torti as its principal deputy commissioner and new chief scientist.
WASHINGTON, March 11 (UPI) -- The U.S. Food and Drug Administration has selected Dr. Janet Woodcock to become the agency's director of drug evaluation and research.
WASHINGTON, Oct. 25 (UPI) -- The U.S. Food and Drug Administration announced the creation Thursday of an internal pediatric review committee.
WASHINGTON, Oct. 16 (UPI) -- Gerald Masoudi has been named associate general counsel of the food and drug division of the U.S. Department of Health and Human Services.
WASHINGTON, Oct. 15 (UPI) -- U.S. Food and Drug Administration Commissioner Dr. Andrew von Eschenbach has met with Chinese health officials to discuss the safety of imports.
WASHINGTON, Aug. 23 (UPI) -- The U.S. Food and Drug Administration issued a proposal Thursday setting standards for formulating, testing and labeling over-the-counter sunscreen products.
WASHINGTON, July 25 (UPI) -- The U.S. Food and Drug Administration's Nanotechnology Task Force released a report Wednesday urging the agency consider addressing nanotechnology risks.
WASHINGTON, June 7 (UPI) -- The U.S. Food and Drug Administration is requesting safety warnings for diabetes drugs Avandia and Actos after they came under congressional scrutiny.
view more

Quotes

view more
1 of 20
Syrians Protest Against the President Bashar al-Assad
View Caption